Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/09/2003WO2003083108A1 Gene examination method for judging the onset risk of glaucoma
10/09/2003WO2003083106A1 Method of assaying target nucleic acid and kit therefor
10/09/2003WO2003083102A2 Cancer associated protein phosphatases and their uses
10/09/2003WO2003083096A2 Cancer associated protein kinases and their uses
10/09/2003WO2003083073A2 Binding assay employing gpcr 192
10/09/2003WO2003083067A2 Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003083060A2 Crystals and structures of mst3
10/09/2003WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics
10/09/2003WO2003083057A2 Adipocytes and uses thereof
10/09/2003WO2003083051A2 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
10/09/2003WO2003083047A2 MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/09/2003WO2003083044A2 Tissue analogs for in vitro testing and method of use therefor
10/09/2003WO2003083041A2 Cripto-specific antibodies
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003083038A2 Disruption of the redk gene
10/09/2003WO2003082988A1 Nir-fluorescent cyanine dyes, their synthesis and biological use
10/09/2003WO2003082922A1 Antibody against an epitope of the b. burgdorferi flagellar basal rod protein (fbrp)
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082903A2 Hybrid phosphoinositide phospholipids: compositions and uses
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082483A1 Preparation of coatings through plasma polymerization
10/09/2003WO2003082469A2 Device and method for carrying out and continuously monitoring chemical and/or biological reactions
10/09/2003WO2003082342A1 Application of kiaa0172 gene to treatment and diagnosis of diseases and drug discovery
10/09/2003WO2003082335A1 Novel blood sugar controller and method of screening the same
10/09/2003WO2003082317A1 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082258A1 Use of cyr61 for the diagnosis of acute renal failure
10/09/2003WO2003082255A2 Use of mob-5 in pain
10/09/2003WO2003082216A2 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003WO2003082214A2 Human metabolic models and methods
10/09/2003WO2003082203A2 Elastin prevents occlusion of body vessels by vascular smooth muscle cells
10/09/2003WO2003082202A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/09/2003WO2003082189A2 Method for producing pseudo islets
10/09/2003WO2003082098A2 Improving performance of an analyte monitoring device
10/09/2003WO2003082096A1 System and method for managing a patient treatment program
10/09/2003WO2003082092A1 Test strip vial
10/09/2003WO2003082091A2 Integrated sample testing meter
10/09/2003WO2003082072A2 Methods for selecting treatment regimens and predicting outcomes in cancer patients
10/09/2003WO2003082006A2 Methods and compositions for preventing obesity and obesity related disorders
10/09/2003WO2003081997A1 CALPAIN LARGE SUBUNIT (n-CL4) CYSTEINE PROTEASE GENE DISRUPTIONS, AND COMPOSITIONS AND METHODS RELATED THERETO
10/09/2003WO2003081996A2 Non-human transgenic mammals carrying germile mutations in both the p53 andfos genes and their use as a disease model
10/09/2003WO2003060463A3 Methods of screening, determining, developing, and utilizing negative cross resistance toxins
10/09/2003WO2003056330A3 Cell sorting system for the size-based sorting or separation of cells suspended in a flowing fluid
10/09/2003WO2003054505A3 High sensitivity protein workstation and techniques
10/09/2003WO2003052379A3 Rapid immunoassay for rsv
10/09/2003WO2003052115A3 Post-synthesis labeling of nucleic acids and uses thereof
10/09/2003WO2003046558A3 Complement c3 precursor biopolymer markers predictive of type ii diabetes
10/09/2003WO2003042653A3 Sensor for the determination of the dielectric constant of a fuel
10/09/2003WO2003040303A3 Functional assay for agonist activation of receptors
10/09/2003WO2003039234A3 Pharmacogenomics-based system for clinical applications
10/09/2003WO2003038442A3 Processes for producing optimized pharmacophores
10/09/2003WO2003037367A3 New bacterium causing poultry disease and vaccine derived thereof
10/09/2003WO2003036282A3 Sensor element and method for determining nitrogen oxides
10/09/2003WO2003036281A3 Gas sensor
10/09/2003WO2003036280A3 Electro thermometric method and apparatus
10/09/2003WO2003034981A3 Prevention of recurrent viral disease
10/09/2003WO2003031054A3 Arrays having clustered arrangements and methods of making and using them
10/09/2003WO2003029828A3 Screening method for different indications using bnpi and/or dnpi
10/09/2003WO2003023051A3 Lateral flow test format for enzyme assays
10/09/2003WO2003023012A3 Crystal structure of interleukin-22 and uses thereof
10/09/2003WO2003022880A3 Synthetic hcv envelope proteins and their use for vaccination
10/09/2003WO2003018753A3 Multiple-site sample-handling apparatus and method
10/09/2003WO2003016528A3 Oligonucleotide compositions and their use to induce apoptosis
10/09/2003WO2003012131A3 Assays for protease inhibitors, methods and means
10/09/2003WO2003011119A3 Methods and compositions for diagnosis and treatment of vascular conditions
10/09/2003WO2003008971A3 Color contrast system for lateral flow immunoassay tests
10/09/2003WO2003008950A3 Method and device for identifying foreign bodies in a textile material
10/09/2003WO2003003015A3 Methods of preparing multicolor quantum dot tagged beads and conjugates thereof
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2003000865A3 Human secreted proteins
10/09/2003WO2002101353A3 Methods and products for analyzing nucleic acids based on methylation status
10/09/2003WO2002099417A3 Method for detecting a substance and microtiter plate
10/09/2003WO2002097431A3 Method for classifying wine and coffee
10/09/2003WO2002097075A3 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
10/09/2003WO2002096950A9 Fxiii detection for verifying serum sample and sample size and for detecting dilution
10/09/2003WO2002094998A9 Analyzing phosphorylated proteins
10/09/2003WO2002092833A3 Arrays of biological membranes and methods and use thereof
10/09/2003WO2002090934A3 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
10/09/2003WO2002088383A3 Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
10/09/2003WO2002087503A3 Compositions and methods for treating colorectal polyps and cancer
10/09/2003WO2002083936A3 Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
10/09/2003WO2002083929A3 System and method for quantitating transcription factors
10/09/2003WO2002082093A3 Methods to measure lipid antioxidant activity
10/09/2003WO2002079505A3 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci
10/09/2003WO2002077016A3 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
10/09/2003WO2002076286A3 Prognostic methods for breast cancer
10/09/2003WO2002073205A3 Metabolic phenotyping in therapy with immunosuppressants
10/09/2003WO2002071062A3 Diagnosis and treatment of inflammation and hyperactive immune conditions
10/09/2003WO2002071033A3 Dissolution test apparatus
10/09/2003WO2002070746A3 Methods for global profiling gene regulatory element activity
10/09/2003WO2002070744A3 Adenoviral library assay for e2f regulatory genes and methods and compositions for screening compounds
10/09/2003WO2002070701A3 Novel human gnrh receptor
10/09/2003WO2002065126A3 Use of troponin i as a species marker protein for meat speciation in both raw and heat-processed products
10/09/2003WO2002060318A3 Detection of methylated cpg rich sequences diagnostic for malignant cells
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002057491A3 Direct multiplex characterization of genomic dna
10/09/2003WO2002057484A3 Method and test system for identifying substances which protect nerve cells
10/09/2003WO2002056014A3 Methods for encoding and decoding complex mixtures in arrayed assays
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
1 ... 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 ... 3937